Bharat Biotech develops alternate vaccine against COVID-19

Bharat Biotech revealed that it will be starting Phase 1 clinical trials for its new intra-nasal antidote alternate vaccine against corona virus and the trial can being sometime soon in Feb-March 2021. Bharat Biotech has partnered up Washington University School of Medicine to develop medicine to help fight the battle against deadly virus.

According to reports, one drop of vaccine in each nostrils would be sufficient whereas Covaxin requires two shots 28 days apart.